How a Simple Selfie Could Transform Cancer Care and Save Lives
A simple selfie can soon become a powerful tool for predicting not just how old you look, but how long you might live-especially if you are a cancer patient. Scientists at Harvard Medical School and Mass General Brigham unveil FaceAge, an advanced artificial intelligence (AI) system that analyzes facial photographs to estimate a person’s biological age and predict survival outcomes for cancer patients, often more accurately than experienced clinicians.
FaceAge stands out by focusing on biological age, which reflects the true wear and tear on the body shaped by genetics, lifestyle, disease, and environment-rather than just counting the years since birth. The system uses deep learning to extract subtle features from facial images, training on over 58,000 photos of healthy individuals and validating its predictions on more than 6,000 cancer patients across the US and Europe. When testing cancer patients, FaceAge often estimates a biological age about five years higher than their actual age. This “facial age gap” strongly links to poorer survival outcomes, making it a valuable new biomarker for oncologists.
Researchers find that FaceAge serves as a much stronger predictor of survival than chronological age, even when doctors have access to full clinical information. In palliative care settings, FaceAge improves the accuracy of six-month survival predictions when used alongside existing clinical tools. When doctors receive FaceAge data, their own predictions also become more accurate. “This work demonstrates that a photo like a simple selfie contains important information that can help inform clinical decision-making and care plans for patients and clinicians,” says Dr. Hugo Aerts, director of the Artificial Intelligence in Medicine program at Mass General Brigham.
The difference between how old someone looks and their real age proves crucial in cancer care. A 65-year-old who appears biologically younger may respond better to aggressive treatment, while a younger patient who looks older may face higher risk. FaceAge quantifies this “eyeball test” that doctors have long used instinctively, but now with data-driven precision. The tool also finds genetic links between facial aging and senescence genes, which play roles in both aging and cancer development-something chronological age alone does not reveal.
The rise of AI tools like FaceAge aligns with remarkable growth in the artificial intelligence healthcare market. According to MarketsandMarkets, the global AI in healthcare market is set to grow at a compound annual growth rate (CAGR) of 38.6%. This surge is fueled by the increasing adoption of AI for early disease detection, personalized treatment, and improved operational efficiency in healthcare systems worldwide. Attractive opportunities emerge as healthcare providers and technology companies collaborate to harness the power of AI, not only to improve clinical outcomes but also to address the growing challenges of chronic diseases and aging populations. Integrating AI-driven solutions like FaceAge into clinical practice reflects a broader shift toward data-driven, patient-centric healthcare, with the potential to transform how diseases are diagnosed, managed, and prevented in the years ahead.
The creators of FaceAge view it as a step toward more personalized, objective, and equitable cancer care. It can help guide treatment decisions, clinical trial selection, and even early disease detection in the future. However, experts urge caution. Dr. Harvey Castro, an emergency physician and AI expert, notes, “AI models are only as good as the data they train on. If the training data lacks diversity, we risk producing biased results.” Concerns also arise around privacy, consent, and the psychological impact of being told you “look older” than your age. Researchers emphasize that FaceAge should augment, not replace, clinical judgment. More validation across diverse populations remains necessary before it becomes a standard tool in hospitals.
As with all AI in healthcare, strong regulation and transparency remain essential to prevent misuse-such as by insurers or employers-and to ensure fairness across different races, ages, and genders. “This opens the door to a whole new realm of biomarker discovery from photographs,” says Dr. Ray Mak, co-senior author of the study. “But it must operate within a strong ethical framework to truly benefit patients.”
According to Fox News, this AI tool called FaceAge analyzes facial images to predict biological age and cancer survival, providing valuable insights that could improve clinical decision-making and patient care.
MarketsandMarkets Industry News Desk
Letter to EditorGET AHEAD
Top Research Reports to Fuel Your Industry KnowledgeEditor's Pick
Healthcare
Samsung’s Xealth Acquisition Sets New Benchmark in Digital Health Integration
Information and Communication Technology
Revolutionizing B2B Sales Prospecting with AI-Powered Pipeline Intelligence from SalesPlay
Information and Communication Technology
Why Apple’s Interest in Perplexity Could Redefine Generative AI StrategyPODCASTS
Sustainable Digital Transformation & Industry 4.0
Sanjay Kaul, President-Asia Pacific & Japan, Cisco, and host Aashish Mehra, Chief Research Officer, MarketsandMarkets, in conversation on unraveling 'Sustainable Digital Transformation and Industry 4.0'
11 July 2023|S2E12|Listen Now
Generative AI
Prasad Joshi, Senior Vice President-Emerging Technology Solutions, Infosys, and host, Vinod Chikkareddy, CCO, MarketsandMarkets, in exploring the recent advances in AI and the generative AI space.
7 Nov 2023|S2E13|Listen Now
Artificial Intelligence (AI) in Healthcare Market
Attractive Opportunities in the Artificial Intelligence (AI) in Healthcare Market
Selfies Become Life-Saving Tools as AI Predicts Cancer Survival with Unmatched Accuracy
